Coronavirus – Major US Decision Made on Pfizer / Biontech Vaccine



[ad_1]

Portfolio Signature for Christmas too!

Key analysis and exclusive content under the tree. You can even give a last-minute gift to someone with a one-year Portfolio Signature subscription. And if you buy an annual subscription for multiple friends, friends and family at the same time, you can also get a quantity discount. So in addition to being a useful gift for the holidays, it can even support the production of quality inexpensive content. Know more

In a public meeting of the board held remotely, seventeen people supported the decision, four voted against it and there was one abstention. The final decision to approve a vaccine is made by the FDA, which generally follows the non-binding recommendations of the expert panel.

Observers say all of this suggests that the Pfizer / BioNTech vaccine will soon be approved in the United States.

On Tuesday, the FDA already rated the vaccine as safe and effective. On Wednesday, the US Department of Health announced that the Pfizer / BioNTech vaccine would be used in hospitals and nursing homes next week.

The Pfizer / BioNTech vaccine has also been approved in the UK and Canada, and the European Medicines Agency (EMA) plans to complete the vaccine evaluation by December 29, although it said it could change this date.

The United States is the country most affected by the epidemic in the world. To date, more than 15 million people have been identified and the number of deaths exceeds 289,000.

Democratic presidential candidate Joe Biden has announced that he intends to vaccinate hundreds of millions of American citizens against the coronavirus in the first 100 days of his presidency.



[ad_2]